Add together drug-drug interactions, large doses of individual medications, age-related changes in drug metabolism, and multiple comorbidities, and the result is a high risk of inappropriate polypharmacy. Yet the standard way of deprescribing—reviewing the patient’s medications, identifying which ones should be stopped, and planning a deprescribing regimen such as a taper—does not fully account for the needs of patients with mental illness, according to experts speaking at APA’s Mental Health Services Conference.
“The three-step approach doesn’t really resonate with me, because it doesn’t reflect what I see in my clinical practice,” said Heather Wobbe, D.O., M.B.A., director of emergency psychiatry at Summa Health in Akron, Ohio.
Special Considerations
Citing a 2016
paper in
Psychiatric Services, Wobbe described the special considerations for deprescribing in psychiatry as falling into three buckets: individual factors, environmental factors, and risk.
Individual differences involve timing (when a medication should be deprescribed), how the patient makes meaning of their illness, the strength of the alliance between the patient and care team, and the patient’s coping strategies. “What someone needs at one point in life to stay stable from a mental health perspective may not be what they need now, but you also have to think about patient preferences and the potential rebound effects of deprescribing,” Wobbe said.
Environmental factors include housing, finances, employment, relationships, and season. “I’m from Ohio, and I [think twice] about taking patients off antidepressants in winter because it usually doesn’t work. If you changed up a patient’s medications right after they get fired, that probably isn’t going to go so well either,” Wobbe said. “That’s the reality of it.”
Risks that psychiatrists must consider include relapse, hospitalizations, suicide/homicide, and mandated treatment. “The risk of destabilization is a lot higher for some patients than for others,” Wobbe said.
“If you know your patient has an extensive history of suicide attempts, you have to take that very seriously,” she said. “If a patient sells their house, gets divorced, and moves to Vegas, you’d want to be more cautious with [deprescribing for] them than someone whose manic episodes are less severe.”
Dwight Kemp, M.D., M.S., a psychiatrist in the extended care unit at Kings County Hospital in New York, noted that older patients have their own age-specific risks to consider with medications—such as the increased risk of falls when taking benzodiazepines.
“If a senior falls, there is a risk of head injury, a broken hip, and other events that require hospitalization, which then raises the risk of delirium,” Kemp said. “Long-term use of benzodiazepines is also associated with cognitive impairment.”
Yet one size does not fit all for deprescribing for older patients. “Geriatric patients are some of the most diverse patients we have,” Kemp said. “If you’ve seen one 71-year-old, you’ve seen one 71-year-old. Some are relatively healthy, active, and thriving, and others have lots of comorbidities.”